http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-524612-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0597f9c318d2aeca86db94711c516383 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575 |
filingDate | 1997-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29a4d03cd3f834c07be6826e7de496f5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f02a649a92b143548aedee13d03442fa |
publicationDate | 2004-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | NZ-524612-A |
titleOfInvention | OB fusion protein compositions and methods |
abstract | Disclosed is a DNA sequence and uses thereof , where said DNA sequence encodes a fusion protein optionally having an N-terminal methionine , comprising an antibody constant region or portion thereof attached to the N-terminus of a human OB protein . Such nucleotide sequences and proteins encoded by them are useful in treatment of excess weight , diabetes , high blood lipid level , arterial sclerosis , arterial plaques , insufficient lean muscle mass , insufficient sensitivity to insulin , gall stone formation , and stroke . |
priorityDate | 1996-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 572.